Prostate cancer is the most common non-skin cancer diagnosed among men who live in the United States. The American Cancer Society estimates that there were 220,800 new cases of prostate cancer in the US last year, accounting for over 25% of the three major cancers (rated in terms of mortality rates) that afflict males across all age groups.

While highly treatable and with near 98% long-term survivability rates when diagnosed in its earliest stages, prostate cancer resulted in about 28,000 deaths in 2015, making it the second-leading cause of cancer deaths among men in the United States, trailing only lung cancer.

Learn More

All-Star Celebration Dinner Honorees

2nd Annual All-Star Celebration Dinner

Due to unforeseen travel and schedule issues for a major sponsor, our Executive Board has decided to postpone the Fans for the Cure All-Star Celebration Dinner that had been scheduled for Monday, September 26, 2016.

We are currently working to reschedule this exciting event. The evening will feature many sports and entertainment celebrities and an all-star panel discussion “The Way We Were” moderated by Ed Randall and Steve Garvey.

Read More

Tommy John

Town Hall on Tommy John Surgery

A panel of experts joined Tommy John in at the SVA Theatre in New York City on Tuesday, June 28, to hold an enlightened discussion about pitch counts, best practices for pitching and throwing, the importance of extended recovery periods for young athletes, and the truths and myths of Tommy John surgery.

The impressive list of panelists included one-time Braves pitching coach Leo Mazzone, Yankees’ Dr. Chris Ahmad, and ASMI Research Director Dr. Glenn Fleisig.

Read about the Town Hall

Shop with AmazonSmile + Support Our Work

Shop with AmazonSmile

With AmazonSmile, your online shopping can help support our work to raise awareness about prostate cancer and help keep men healthier.

Go shop on AmazonSmile

We’re Working Every Day to Raise Awareness About Prostate Cancer

At Fans for the Cure we are committed to the reversing national trends by increasing the number of men who undergo PSA screenings for prostate cancer and reducing the growing number of men who are being diagnosed with later-stage variants of the disease. Working closely with our Medical Advisory Board, we also seek to serve as an information repository for men and their families in leading them to the most effective and least invasive treatment options.